OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
Clinical trial NCT00097422 · COMPLETED
Trial details
- NCT number
- NCT00097422
- Sponsor
- Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2005-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.